International Immunology, Vol. 6, No. 10, pp. 1535-1543,October 1994
© 1994 Japanese Society for Immunology
Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance
The Walter and Eliza Hall Institute of Medical Research PO Royal Melbourne Hospital, Victoria 3050, Australia
Correspondence to: Correspondence to. E. Handman
It is well established that BALB/c mice can be protected from fatal infection with Leishmania major by prophylactic intravenous (i.v.) immunization with irradiated parasites. Protection is critically dependent on the route of injection with i.v. injection being protective and subcutaneous injection not protective. We used this BALB/c-L major model system to investigate this phenomenon. We analyzed quantitatively the parasite-specific, CD4+ T cell mediated immune responses by limiting dilution. Subcutaneous vaccination resulted in priming of CD4+ precursor T cells, whereas i.v. vaccination was ineffectual. Moreover, i.v. injection prevented the increase in the number of specific precursor cells induced by infection of normal mice during the first weeks post-challenge with virulent parasites. We show here that this was not due to the elimination of the virulent challenge parasites as a result of immunity nor to inefficient antigen presentation of the irradiated organisms after i.v. injection, The data presented here suggest that i.v. injection results in tolerizatlon rather than immunization. Tolertzation as a mechanism of host protection is consistent with earlier observations that transient immunosuppresslon results in cure of L. major infection in BALB/c mice. Transfer of antigen presenting cells (APC) isolated from spleens of mice injected previously with irradiated parasites mimicked to some extent the effect of i.v. immunization with irradiated parasites. The possible involvement of these APC in decreasing the parasite-specific T cell response is discussed.
Keywords: intravenous immunization, limiting dilution analysis, lymphokines, T cell subsets
Received 22 April 1994, accepted 23 June 1994.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Aebischer, M. Wolfram, S. I. Patzer, T. Ilg, M. Wiese, and P. Overath Subunit Vaccination of Mice against New World Cutaneous Leishmaniasis: Comparison of Three Proteins Expressed in Amastigotes and Six Adjuvants Infect. Immun., March 1, 2000; 68(3): 1328 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Stacey and J. M. Blackwell Immunostimulatory DNA as an Adjuvant in Vaccination against Leishmania major Infect. Immun., August 1, 1999; 67(8): 3719 - 3726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E. E. Sercarz, F. L. Graham, J. Gauldie, and T. A. Braciak A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice J. Immunol., January 15, 1999; 162(2): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Peters, T Aebischer, Y. Stierhof, M Fuchs, and P Overath The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes J. Cell Sci., January 12, 1995; 108(12): 3715 - 3724. [Abstract] [PDF] |
||||


